Drug Discovery Unchained: What The Drug!? #2

webinar

Wed, 14 Aug 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

Drug Discovery Unchained: What The Drug!? #2

What happens when somebody asks you to do drug discovery? No preparation, no script, no nothing. Just live performing and sharing your thoughts.

This is “What The Drug!?”: a live session tackling a drug discovery challenge using BioSolveIT tools, with the aim of reaching a conclusion in a reasonable time frame. What is the challenge? We do not know. Everything will be revealed during the stream, and we will see how things unfold.

The first session was a good starting point, but let’s see how things develop. Dive into the session, discuss together, and explore on-the-fly compound design.

Current news

category
Events
Save the Date: UK-QSAR 2026 in Edinburgh on 21 April 2026
December 8, 2025 12:53 CET
The Spring UK-QSAR & Cheminformatics Society Meeting will take place on 21 April 2026 in Edinburgh and will be jointly hosted by BioSolveIT and Enamine. Once again, we warmly invite all cheminformatics enthusiasts to join us for scientific exchange, high-calibre talks and a poster session. As always, the meeting is...
Read on
category
Challenge
Winter 2025 Scientific Challenge Deadline Approaching
November 10, 2025 10:38 CET
We invite researchers in academia (students, postdocs, professors), non-profit organizations, and individuals to participate in our quarterly Scientific Challenge. Take advantage of our wide array of software to help meet your drug discovery goals. How to Participate Just send us a proposal for the project you would like to advance...
Read on
category
Events
Recordings of the BioSolveIT Day 2025 Available
October 15, 2025 13:39 CEST
Missed BioSolveIT Day 2025? The recordings from BioSolveIT Day 2025 are now live! Packed with practical insights for medicinal and computational chemists, the sessions showcase how SeeSAR, infiniSee, Chemical Space DockingĀ®, and CoLibri accelerate real-world discovery, from pocket-aware design and HYDE-guided decisions to trillion-scale, synthesizable chemical space exploration and in-house...
Read on